EANS-Adhoc: Oxygen Biotherapeutics Reports Second Quarter FY2012 Financial Results. -Management to host teleconference to discuss financial results on December 19-
issuer: Oxygen Biotherapeutics Inc. One Copley Parkway, Suite 490 US-27560 Morrisville, NC phone: +1 (919) 855 21 12 FAX: +1 (919) 806 44 17 mail: e.corliss@oxybiomed.com WWW: www.oxybiomed.com sector: Biotechnology ISIN: US69207P2092 indexes: SSIRT stockmarkets: Nasdaq: New York, Main Standard: SIX Swiss Exchange ...